 |
AMs
asked to shout down diabetes myths for Diabetes Week |
| |
Diabetes UK Cymru and Jeff Cuthbert AM are asking
AMs to shout down the myths about diabetes in an event at the Welsh
Assembly for Diabetes Week (Diabetes UK) |
| |
|
|
Much
to do in tackling this diabetes epidemic |
| |
Following the first meeting of the new Cross-Party
Group on Diabetes at the National Assembly in March, Dai Williams,
national director of Diabetes UK Cymru, explains why it is needed
more than ever (Wales Online) |
| |
|
|
NCD
alliance website launched |
| |
In conjuction with the World Health Assembly
in Geneva, the Non-Communicable Disease (NCD) Alliance has launched
a unique global online platform to facilitate the campaign against
the growing epidemic of NCDs (International Diabetes Federation) |
| |
|
|
The
effect of healthcare provider education on diabetes management
of hospitalised patients |
| |
Implementing an educational programme for healthcare
providers had significant effects on the lowering of mean BG values
and the incidence of hyperglycaemia, but increased the risk of
hypoglycaemia (International Journal of Clinical Practice) |
| |
|
|
Type
2 Diabetes Comorbidities and Treatment Challenges |
| |
Many patients with type 2 diabetes have disease-related
complications or comorbid conditions, which can hinder disease
management. In choosing antihyperglycemic medications, efficacy
for improving glycemic control must be balanced against safety
and tolerability issues that can adversely affect these complications
and comorbidities (Postgraduate Medicine) |
| |
|
|
Record
Number of Medicines Currently in Development to Treat Diabetes |
| |
A record 235 new medicines to treat diabetes,
one of the fastest-growing diseases in America, are being developed
by America's pharmaceutical research and biotechnology companies,
according to a national report (PubMed Diabetes) |
| |
|
|
Long
term treatment with metformin in patients with type 2 diabetes
and risk of vitamin B-12 deficiency |
| |
Randomised placebo controlled trial (BMJ) |
| |
|
|
An
update on the treatment of type 1 and type 2 diabetes mellitus:
focus on insulin detemir, a long-acting human insulin analog |
| |
Recent guidelines for treatment of type 2 diabetes
suggest starting intensive therapy of hyperglycemia at an early
stage of diabetes and recommend therapeutic options that provide
the possibility of reaching HbA1c goals individually, with a low
risk of hypoglycemia or other adverse effects of treatment. The
properties of insulin detemir match these requirements (Vascular
Health and Risk Management) |
| |
|
|
EURADIA
DIAMAP Road Map reports |
| |
Road Map reports are now available for a 1-month
consultation period open to the general public (DIAMAP) |
| |
|
|
Study
links viral infection to juvenile diabetes |
| |
In a small study of 112 children with juvenile
diabetes, Antonio Toniolo of the University of Insubria in Varese,
Italy, found that more than 80 percent had evidence of enterovirus
infection in their blood (Reuters) |
| |
|
|
Type
3 Diabetes: Brain Diabetes? |
| |
Intensive study is underway in an attempt to
better characterize type 3 diabetes and to develop preventative
and therapeutic strategies (US Pharmacist) |
| |
|
|
Endothelial
Cell–Derived Endothelin-1 Promotes Cardiac Fibrosis in Diabetic Hearts Through Stimulation
of Endothelial-to-Mesenchymal Transition |
| |
These results provide new insights suggesting
that diabetes mellitus–induced cardiac fibrosis is associated with the emergence of fibroblasts from
endothelial cells and that this endothelial-to-mesenchymal transition
process is stimulated by ET-1 (Circulation) |
| |
|
|
TeleHealth
Improves Diabetes Self-Management in an Underserved Community:
Diabetes TeleCare |
| |
Telehealth effectively created access to successfully
conduct a one year remote DSME by a nurse CDE and dietitian that
improved metabolic control and reduced cardiovascular risk in an
ethnically diverse and rural population (Diabetes Care) |
| |
|
|
Comments
about Glycosmedia |
| |
If you would like to leave a comment about Glycosmedia
that can be published on the website then please use the link to
our online form on this page or contact the editor Jim Young by e-mail |
| |
|
